Reversal Agents for Oral Antiplatelet and Anticoagulant Treatment During Bleeding Events: Current Strategies

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|9|1406-1423

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.9, 2017-04, pp. : 1406-1423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral Antiplatelet and Anticoagulant Agents in the Prevention and Management of Ischemic Stroke

By  

Current Pharmaceutical Design, Vol. 23, Iss. 9, 2017-04 ,pp. : 1377-1391

Bentham Science Publishers

Access to resources Recommend Favorite

Avoidance of Bleeding During Surgery in Patients Receiving Anticoagulant and/or Antiplatelet Therapy: Pharmacokinetic and Pharmacodynamic Considerations

By Sebastian Harder  

Clinical Pharmacokinetics, Vol. 43, Iss. 14, 2004-01 ,pp. : 963-981

Adis International

Access to resources Recommend Favorite

Platelet Activation, and Antiplatelet Targets and Agents: Current and Novel Strategies

By Xiang Yao-Zu   Xia Ye   Gao Xiu-Mei   Shang Hong-Cai   Kang Li-Yuan   Zhang Bo-Li  

Drugs, Vol. 68, Iss. 12, 2008-01 ,pp. : 1647-1664

Adis International

Access to resources Recommend Favorite

Oral Antiplatelet Treatment in STEMI: Current Practice and Future Considerations

By  

Current Pharmaceutical Design, Vol. 22, Iss. 29, 2016-09 ,pp. : 4577-4582

Bentham Science Publishers

Access to resources Recommend Favorite

Current strategies with eptifibatide and other antiplatelet agents in percutaneous coronary intervention and acute coronary syndromes

By Jennings Lisa K  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 727-737

Informa Healthcare

Access to resources Recommend Favorite